Predictive Value of Neuromuscular Ultrasound of Cranial Nerves in Guillain-Barré Syndrome

Overview

1. Sensitivity and specificity of cranial neuromuscular US to detect the prognosis of Guillain Barre Syndrome 2. Correlation of US values with motor, respiratory and autonomic complications of Guillain Barre Syndrome

Guillain-Barré syndrome (GBS) is a dangerous and under certain circumstances life-threatening immune-mediated polyneuropathy of acute onset, often subsequent to respiratory or diarrheal illness. Patients usually present with distal onset of slight sensory symptoms such as numbness and tingling followed by ascending weakness of arms and legs, often involving cranial nerves Typical clinical findings are symmetric, flaccid paresis, reduced or absent deep tendon reflexes, and slight sensory symptoms only. Many variants of GBS such as pharyngeal-brachial or bulbar variants exist; the Miller-Fisher syndrome (MFS) with ataxia, areflexia, and oculomotor dysfunction; or the Elsberg syndrome with accentuated involvement of the autonomic nervous system. Diagnosis of GBS is normally based on typical clinical onset, laboratory findings, and electrophysiological studies. In literature, Campylobacter jejuni infection is the most commonly identified precipitant of GBS. Cytomegalovirus, Epstein-Barr virus, human immunodeficiency virus (HIV), and Zika virus have also been reported with GBS \[5\]. A small percentage of patients develop GBS after other triggering events such as immunization, surgery, trauma, and bone-marrow transplantation. Autonomic dysfunction (AD) in GBS predominantly occurs in the acute phase of the illness but can manifest in the recovery phase too. The exact mechanism remains unknown but probably involves dysfunction in the sympathetic and parasympathetic systems \[8\]. AD in GBS is observed in 70% of the cases \[7\]; features including tachycardia, bradycardia, facial flushing, hypertension alternating with hypotension, orthostatic hypotension, anhydrosis or diaphoresis, and urinary retention while gastrointestinal autonomic manifestation includes diarrhea or constipation \[9\]. Severe autonomic dysfunction is an important factor to recognize and treat accordingly as this is occasionally associated with a sudden death rate of 5-7% \[10,11\]. Guillain-Barré Syndrome (GBS) is often accompanied by respiratory failure that necessitates mechanical ventilation (MV).1 About 20-30% of cases require respiratory support.2-4 Major complications, including pulmonary infections, sepsis and pulmonary embolism, are reported in 60% of intubated patients with GBS.5, 6 The worldwide mortality rate for ventilated patients ranges from 15% to 30%, with survivors usually having poor outcomes.7 . Multiple clinical and biological parameters have been identified as risk factors for impending respiratory failure in GBS,9, 10 including cranial nerve involvement, disability grade on admission, rapidly progressive motor weakness, an absence of deep tendon reflexes, autonomic dysfunction, and features of nerve conduction block on electromyography.11-14 Facial nerve is commonly involved in GBS, occurring in at least half of patients. Other cranial nerves like bulbar nerves, abducent, oculomotor, optic, hypoglossal nerves are less often affected Ultrasound (US) is a reliable, effective, noninvasive, and well tolerated technique that allows multiple nerves to be examined in a relatively short period. Ultrasound (US) studies have demonstrated patchy enlargement of cranial nerves in Guillain-Barré syndrome (GBS). However, whether ultrasound yields useful information for early classification of GBS has not been established. We aimed to evaluate nerve ultrasound in patients with GBS in assuit university hospital. As confirmed in acquired immune-mediated neuropathies and inherited demyelinating neuropathies peripheral nerves can exhibit quantifiable enlargement in increased cross-sectional areas (CSA). We follow up the patient to see improvement and accordingly we see the predictive value of neuromuscular ultrasound of cranial nerves in Guillain-Barré syndrome

Conditions

Interventions

Eligibility

Outcomes

Central Contacts